Analytical expression of effective afterload in aortic and mitral regurgitation.
Effective arterial elastance (Ea) is the coupling parameter between the left ventricle and peripheral circulation in normal subjects. If left ventricular end systolic pressure (Pes), contractility (Es) and Ea are known, left ventricular end diastolic volume (LVEDV) and ejection fraction of the ventricle are completely determined. The aim of this study was to give an analytical expression for Ea in patients with mitral and aortic regurgitation, and predict both LVEDV and the effect of vasodilator therapy on LVEDV. Twenty-three subjects with atypical chest pain, 15 patients with mitral insufficiency and 11 with aortic insufficiency underwent diagnostic cardiac catheterization, coronary angiography, and left ventricular cineangiography, which was analyzed quantitatively. Ea was 2.05 +/- 0.63 in normal subjects, while it was 1.28 +/- 0.71 and 1.57 +/- 0.87 in patients with mitral and aortic insufficiency, respectively. All these groups differed with ANOVA test (p = 0.0031). We tested the ability of the analytical expressions for Ea in normal subjects, and patients with mitral insufficiency or aortic insufficiency to predict measured Ea and LVEDV. Ea and LVEDV were predicted rather accurately in every case (p < 0.0001). We used published data to test the effect of resistance modulation on LVEDV. Predicted and measured LVEDV were linearly correlated both in aortic (p < 0.0001) and mitral insufficiency (p = 0.027). Moreover, in some cases a left ventricular enlargement after vasodilator therapy could be anticipated because of an unbalanced decrease in resistance and heart rate. Ea seems to be the coupling parameter between the left ventricle and the peripheral circulation not only in normal subjects, but also in patients with mitral or aortic regurgitation; its measurement before administering vasodilating drugs may be useful in order to predict the effects on LVEDV, and achieve an optimal ventriculoarterial coupling.
Razzolini
R
R
Department of Hemodynamics and Cardiology, University of Padova Medical School, Italy.
Ramondo
A
A
Isabella
G
G
Cardaioli
P
P
Vaccari
D
D
Carasi
M
M
De Leo
A
A
Chioin
R
R
Suga
H
H
Dalla-Volta
S
S
D001022:Aortic Valve Insufficiency / Q000188:drug therapy / Q000503:physiopathology*; D003187:Compliance; D003971:Diastole; D006339:Heart Rate; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000188:drug therapy / Q000503:physiopathology*; D009200:Myocardial Contraction; D013318:Stroke Volume; D014655:Vascular Resistance; D014665:Vasodilator Agents / Q000627:therapeutic use; D016277:Ventricular Function, Left; D017725:Ventricular Pressure
D014665:Vasodilator Agents